z-logo
Premium
Co‐evolution of M ycobacterium tuberculosis and H omo sapiens
Author(s) -
Brites Daniela,
Gagneux Sebastien
Publication year - 2015
Publication title -
immunological reviews
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.839
H-Index - 223
eISSN - 1600-065X
pISSN - 0105-2896
DOI - 10.1111/imr.12264
Subject(s) - tuberculosis , virulence , biology , mycobacterium tuberculosis , genotype , homo sapiens , disease , human pathogen , genetics , obligate , pathogen , virology , tuberculosis vaccines , immunology , gene , medicine , ecology , pathology , sociology , anthropology
Summary The causative agent of human tuberculosis ( TB ), M ycobacterium tuberculosis , is an obligate pathogen that evolved to exclusively persist in human populations. For M . tuberculosis to transmit from person to person, it has to cause pulmonary disease. Therefore, M . tuberculosis virulence has likely been a significant determinant of the association between M . tuberculosis and humans. Indeed, the evolutionary success of some M . tuberculosis genotypes seems at least partially attributable to their increased virulence. The latter possibly evolved as a consequence of human demographic expansions. If co‐evolution occurred, humans would have counteracted to minimize the deleterious effects of M . tuberculosis virulence. The fact that human resistance to infection has a strong genetic basis is a likely consequence of such a counter‐response. The genetic architecture underlying human resistance to M . tuberculosis remains largely elusive. However, interactions between human genetic polymorphisms and M . tuberculosis genotypes have been reported. Such interactions are consistent with local adaptation and allow for a better understanding of protective immunity in TB . Future ‘genome‐to‐genome’ studies, in which locally associated human and M . tuberculosis genotypes are interrogated in conjunction, will help identify new protective antigens for the development of better TB vaccines.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here